Addus HomeCare (NASDAQ:ADUS) Releases Earnings Results, Beats Estimates By $0.02 EPS

Addus HomeCare (NASDAQ:ADUS) posted its quarterly earnings results on Monday. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02, Briefing.com reports. The firm had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The company’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.03 earnings per share.

Addus HomeCare Stock Down 5.7 %

Shares of ADUS traded down $7.36 during trading hours on Tuesday, reaching $121.60. 73,133 shares of the company traded hands, compared to its average volume of 130,852. The stock has a market capitalization of $2.20 billion, a P/E ratio of 28.13, a P/E/G ratio of 2.29 and a beta of 1.04. The business has a fifty day moving average price of $129.93 and a 200-day moving average price of $120.66. Addus HomeCare has a 12-month low of $81.51 and a 12-month high of $136.12.

Insider Transactions at Addus HomeCare

In other news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now owns 3,366 shares in the company, valued at $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares in the company, valued at approximately $429,165. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 22,917 shares of company stock valued at $3,050,082 in the last three months. 4.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Stephens reissued an “overweight” rating and set a $138.00 price target on shares of Addus HomeCare in a research report on Tuesday, August 6th. KeyCorp began coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target for the company. Royal Bank of Canada reiterated an “outperform” rating and set a $141.00 price objective on shares of Addus HomeCare in a research note on Tuesday, September 3rd. TD Cowen boosted their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Finally, Oppenheimer lifted their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $131.38.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.